Finance
A biotech founded by a 32-year-old just failed a key Alzheimer’s drug trial (AXON)
Axovant founder Vivek RamaswamyLisa Lake/Getty Axovant, a company founded by 32-year-old Vivek Ramaswamy, just failed a key late-stage trial for its Alzheimer’s...